Skip to search formSkip to main content

azilsartan medoxomil

Known as: (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-((2'-(5-oxo-4,5-dihydro-1,2,4- oxadiazol-3-yl)biphenyl-2-yl)methyl)-1H-benzo(d)imidazole-7-carboxylate, Azilsartan medoxomilo, Azilsartanum medoxomilum 
A medoxomil prodrug of azilsartan, an angiotensin II receptor antagonist with antihypertensive activity. Upon hydrolysis, azilsartan selectively and… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
The angiotensin II type 1 (AT1) receptor blocker (ARB) candesartan strongly reduces blood pressure (BP) in patients with… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
2012
2012
BACKGROUND Chlorthalidone has proven efficacy to reduce cardiovascular morbidity and mortality, yet it is infrequently used in… Expand
Is this relevant?
2012
2012
This study compared the efficacy and safety of fixed-dose combinations (FDCs) of the angiotensin II receptor blocker azilsartan… Expand
Is this relevant?
2012
2012
Azilsartan medoxomil, an effective, long-acting angiotensin II receptor blocker, is a new treatment for hypertension that is also… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Azilsartan medoxomil is an angiotensin receptor blocker (ARB) being developed for hypertension treatment. To compare this ARB… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Azilsartan medoxomil (AZL-M) is a unique angiotensin II receptor blocker (ARB) under development for the treatment of… Expand
  • table I
  • figure 3
  • figure 1
  • figure 2
  • table II
Is this relevant?
2011
2011
Hypertension affects approximately one in three adults in the U.S. and is a major risk factor for cardiovascular disease. Each… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
Is this relevant?
2011
2011
The pharmacological profile of a novel angiotensin II type 1 receptor blocker, azilsartan medoxomil, was compared with that of… Expand
Is this relevant?
2011
2011
BACKGROUND Azilsartan medoxomil is a newly approved angiotensin receptor blocker (ARB) reported to lower 24-h blood pressure more… Expand
Is this relevant?
2011
2011
Increased expression of plasminogen activator inhibitor type-I (PAI-1) in vessel walls seems to accelerate atherosclerosis… Expand
Is this relevant?